middle.news
How Is Invex Therapeutics Advancing Alzheimer’s Treatment with Exenatide?
6:02pm on Thursday 22nd of January, 2026 AEDT
•
Healthcare
Read Story
How Is Invex Therapeutics Advancing Alzheimer’s Treatment with Exenatide?
6:02pm on Thursday 22nd of January, 2026 AEDT
Key Points
Exenatide shows potential neuroprotective effects in Tessara’s Alzheimer’s model
Reduction in neurofilament light chain and inflammatory markers observed
Board resignations and new appointments reshape corporate leadership
Annual General Meeting deferred to accommodate governance changes
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invex Therapeutics (ASX:IXC)
OPEN ARTICLE